0001179110-21-001510.txt : 20210210 0001179110-21-001510.hdr.sgml : 20210210 20210210162429 ACCESSION NUMBER: 0001179110-21-001510 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210208 FILED AS OF DATE: 20210210 DATE AS OF CHANGE: 20210210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Utter Christine Marie CENTRAL INDEX KEY: 0001707685 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 21614194 MAIL ADDRESS: STREET 1: C/O PTC THERAPEUTICS, INC. STREET 2: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 4 1 edgar.xml FORM 4 - X0306 4 2021-02-08 0 0001070081 PTC THERAPEUTICS, INC. PTCT 0001707685 Utter Christine Marie C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080 0 1 0 0 SVP, Finance & CAO Common Stock 2021-02-08 4 M 0 2657 33.02 A 19166 D Common Stock 2021-02-08 4 S 0 2657 66.00 D 16509 D Stock Option (Right to Buy) 33.02 2021-02-08 4 M 0 2657 33.02 D 2029-01-21 Common Stock 2657 21250 D Stock Option (Right To Buy) 490.8 2021-04-27 Common Stock 74.0 74 D Stock Option (Right To Buy) 218.4 2022-01-10 Common Stock 21.0 21 D Stock Option (Right To Buy) 40.45 2024-09-23 Common Stock 4688.0 4688 D Stock Option (Right To Buy) 51.0 2025-01-02 Common Stock 17800.0 17800 D Stock Option (Right to Buy) 18.01 2028-01-02 Common Stock 10000 10000 D Stock Option (Right To Buy) 33.02 2029-01-21 Common Stock 10100.0 10100 D Stock Option (Right To Buy) 51.16 2030-01-28 Common Stock 23800.0 23800 D Stock Option (Right to Buy) 66.49 2031-01-05 Common Stock 50750 50750 D This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on December 14, 2020. This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020. Currently exercisable. This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019. This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023. This option was granted on January 29, 2020, and vests over four years, with 25% of the shares underlying the option vesting on January 29, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 29, 2021. Represents an option award of 33,250 options and an option award of 17,500 options. These option awards were each granted on January 6, 2021, and each vests over four years, with 25% of the shares underlying the option vesting on January 6, 2022, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 6, 2022. /s/ Avraham S. Adler, attorney-in-fact 2021-02-10